Robin Swartz - Feb 7, 2022 Form 3 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: Chief Operating Officer
Signature: /s/ Robert Hesslein, as Attorney-in-Fact for Robin Swartz
Stock symbol: VYGR
Transactions as of: Feb 7, 2022
Transactions value $: $0
Form type: 3
Date filed: 2/9/2022, 03:26 PM
Next filing: Mar 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VYGR	Common Stock						58K	Feb 7, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VYGR	Stock Option (Right to Buy)							Feb 7, 2022	Common Stock	76.5K	$8.43	Direct	F2
holding	VYGR	Stock Option (Right to Buy)							Feb 7, 2022	Common Stock	120K	$2.85	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes shares of common stock issuable under restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "2015 Plan") and shares of common stock issuable under RSUs awarded to the Reporting Person, not pursuant to any pre-existing equity plan of Voyager Therapeutics, Inc. (the "Company"), as an inducement material to the Reporting Person's commencement of employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The RSUs vest periodically, and each RSU represents the right to receive one share of common stock upon vesting.
F2	This stock option was issued, not pursuant to any pre-existing equity plan of the Company, as an inducement material to the Reporting Person's commencement of employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The vesting commencement date of the option is the grant date, January 11, 2021. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
F3	This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date, January 13, 2022. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Limited Power of Attorney